Engineered human B cells targeting tumor-associated antigens exhibit antigen presentation and antibody-mediated functions.

Boucher A, Anderson C, Hinman R, Kindschuh M, Fung J, Wang T, Klooster I, Kim E, Roth C, Vander Oever M, Khan B, Zelikson N, Vagima Y, Saribasak H, Santry L, Klapper LN, Hess S, Mooney J, Bublik DR, Laken H, Barzel A, Borden P, Plewa C, Chadbourne AM, Bridgen D, Nahmad AD.

Open source

DOI: 10.3389/fimmu.2025.1621222
Published: 2025-07-30
Container: Front Immunol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1621222,
  title = {Engineered human B cells targeting tumor-associated antigens exhibit antigen presentation and antibody-mediated functions.},
  author = {Boucher A and  Anderson C and  Hinman R and  Kindschuh M and  Fung J and  Wang T and  Klooster I and  Kim E and  Roth C and  Vander Oever M and  Khan B and  Zelikson N and  Vagima Y and  Saribasak H and  Santry L and  Klapper LN and  Hess S and  Mooney J and  Bublik DR and  Laken H and  Barzel A and  Borden P and  Plewa C and  Chadbourne AM and  Bridgen D and  Nahmad AD.},
  year = {2025},
  journal = {Front Immunol},
  doi = {10.3389/fimmu.2025.1621222},
  url = {https://doi.org/10.3389/fimmu.2025.1621222}
}

RIS

TY  - JOUR
TI  - Engineered human B cells targeting tumor-associated antigens exhibit antigen presentation and antibody-mediated functions.
AU  - Boucher A
AU  -  Anderson C
AU  -  Hinman R
AU  -  Kindschuh M
AU  -  Fung J
AU  -  Wang T
AU  -  Klooster I
AU  -  Kim E
AU  -  Roth C
AU  -  Vander Oever M
AU  -  Khan B
AU  -  Zelikson N
AU  -  Vagima Y
AU  -  Saribasak H
AU  -  Santry L
AU  -  Klapper LN
AU  -  Hess S
AU  -  Mooney J
AU  -  Bublik DR
AU  -  Laken H
AU  -  Barzel A
AU  -  Borden P
AU  -  Plewa C
AU  -  Chadbourne AM
AU  -  Bridgen D
AU  -  Nahmad AD.
PY  - 2025
JO  - Front Immunol
DO  - 10.3389/fimmu.2025.1621222
UR  - https://doi.org/10.3389/fimmu.2025.1621222
ER  -

APA

A, B., C, A., R, H., M, K., J, F., T, W., I, K., E, K., C, R., M, V. O., B, K., N, Z., Y, V., H, S., L, S., LN, K., S, H., J, M., DR, B., H, L., A, B., P, B., C, P., AM, C., D, B., & AD., N. (2025). Engineered human B cells targeting tumor-associated antigens exhibit antigen presentation and antibody-mediated functions.. Front Immunol. https://doi.org/10.3389/fimmu.2025.1621222

Source records

europe-pmc · retrieved 2026-09-26T16:44:27.390Z
doaj · retrieved 2026-09-26T16:44:27.390Z